Concepedia
Statistics
Publications
21
Citations
1.3K
H-Index
18
Active since
2015
Affiliations
City University of Hong Kong(Current)
City University of Hong Kong, Shenzhen Research Institute
Shenzhen University Health Science Center
University of Edinburgh
Kowloon Hospital
Zoufeng Xu is an author at City University of Hong Kong specializing in anticancer prodrug design, chemotherapy, and platinum compounds.
Publications per year
2015–2024
A Photocaged, Water-Oxidizing, and Nucleolus-Targeted Pt(IV) Complex with a Distinct Anticancer Mechanism
Zhiqin Deng, Na Wang, Yingying Liu et al. · Journal of the American Chemical Society · 2020 · 229 citations
Pharmacy, Medicinal Chemistry, Pharmacology +17
Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red Light
Zhigang Wang, Na Wang, Shun‐Cheung Cheng et al. · Chem · 2019 · 176 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +14
Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs
Zoufeng Xu, Zhigang Wang, Zhiqin Deng et al. · Coordination Chemistry Reviews · 2021 · 168 citations
A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance
Zhigang Wang, Zoufeng Xu, Guangyu Zhu · Angewandte Chemie International Edition · 2016 · 137 citations
Medicine, Oncology, Pharmacology +17
A Cisplatin‐Loaded Immunochemotherapeutic Nanohybrid Bearing Immune Checkpoint Inhibitors for Enhanced Cervical Cancer Therapy
Na Wang, Zhigang Wang, Zoufeng Xu et al. · Angewandte Chemie International Edition · 2018 · 124 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 21